| Name | N-(3-chloro-5-fluorophenyl)-4-nitrobenzo[c][1,2,5]oxadiazol-5-amine | 
|---|---|
| Synonyms | HIF2α-IN-2 | 
| Description | TC-S 7009 is a potent and selective HIF-2α inhibitor with a Kd of 81 nM. TC-S 7009 is more selective for HIF-2α than HIF-1α (Kd ≫ 5 μM). TC-S 7009 disrupts HIF-2α heterodimerization, decreases DNA-binding activity, and reduces HIF-2α target gene expression[1][2]. | 
|---|---|
| Related Catalog | |
| Target | 
                                
                                 Kd: 81 nM (HIF-2α)[1]  | 
                        
| In Vitro | TC-S 7009 (0-100 µM; 72 hours; HPF cells) treatment shows greater inhibition of cell proliferation in hypoxic conditions than that in normoxic conditions[2]. TC-S 7009 (50 μM) treatment almost completely inhibits the hypoxia-induced NFATc2 nuclear translocation[2]. Cell Proliferation Assay[2] Cell Line: HPF cells in hypoxic conditions Concentration: 0-100 µM Incubation Time: 72 hours Result: Showed greater inhibition of cell proliferation in hypoxic conditions than that in normoxic conditions. | 
| References | 
| Molecular Formula | C12H6ClFN4O3 | 
|---|---|
| Molecular Weight | 308.65200 | 
| Exact Mass | 308.01100 | 
| PSA | 96.77000 | 
| LogP | 4.26330 | 
| Symbol | 
                                
                                 
                                
                                GHS06  | 
                        
|---|---|
| Signal Word | Danger | 
| Hazard Statements | H301-H413 | 
| Precautionary Statements | P301 + P310 | 
| RIDADR | UN 2811 6.1 / PGIII |